PRIA, Government Policy, Made Personal

Summary

The Department of Health and Human Services, through the Centers for Disease Control and Prevention (CDC), must set up studies and work with States and others to collect samples and test for different types of human papillomavirus (HPV). The CDC must build and study a system that shows how common HPV is in different ages, places, and body sites, and must report progress to Congress within one year after the law takes effect. The CDC must also do prevention research — studying how an HPV diagnosis affects people, testing ideas for public education, surveying doctors and the public about HPV, and then creating and sharing educational materials based on what it learns. The Department must give a progress report to Congress within one year after the law takes effect and a final report with findings and prevention strategies within three years. The Department must make and give out clear materials for doctors and the public about how HPV spreads, health problems it can cause (including its link to cervical cancer), what science shows about condoms and HPV, and why regular Pap tests and other checks matter. All mass-produced STD materials must include medically accurate information about condom effectiveness for the STD they address. The Department must run a national campaign to raise awareness of gynecologic cancers, keep written materials available, and run public service announcements telling women to talk with doctors about risks and warning signs. The Department had to send a detailed report to Congress within 6 months after January 12, 2007, then a strategy within 3 months after that report, and must have fully implemented these duties by March 1, 2008 with a certification to Congress by April 30, 2008 (or explain every 3 months why it has not). The law authorizes $16,500,000 for fiscal years 2007–2009 and $18,000,000 for fiscal years 2012–2014 for these activities.

Title 42, §247b–17

The Public Health and Welfare, Source: USLM XML via OLRC

(a)(1)The Secretary, acting through the Centers for Disease Control and Prevention, shall—

(A)enter into cooperative agreements with States and other entities to conduct sentinel surveillance or other special studies that would determine the prevalence in various age groups and populations of specific types of human papillomavirus (referred to in this section as “HPV”) in different sites in various regions of the United States, through collection of special specimens for HPV using a variety of laboratory-based testing and diagnostic tools; and

(B)develop and analyze data from the HPV sentinel surveillance system described in subparagraph (A).

(2)The Secretary shall make a progress report to the Congress with respect to paragraph (1) no later than 1 year after the effective date of this section.

(b)(1)The Secretary, acting through the Centers for Disease Control and Prevention, shall conduct prevention research on HPV, including—

(A)behavioral and other research on the impact of HPV-related diagnosis on individuals;

(B)formative research to assist with the development of educational messages and information for the public, for patients, and for their partners about HPV;

(C)surveys of physician and public knowledge, attitudes, and practices about genital HPV infection; and

(D)upon the completion of and based on the findings under subparagraphs (A) through (C), develop and disseminate educational materials for the public and health care providers regarding HPV and its impact and prevention.

(2)The Secretary shall make a progress report to the Congress with respect to paragraph (1) not later than 1 year after the effective date of this section, and shall develop a final report not later than 3 years after such effective date, including a detailed summary of the significant findings and problems and the best strategies to prevent future infections, based on available science.

(c)(1)The Secretary shall prepare and distribute educational materials for health care providers and the public that include information on HPV. Such materials shall address—

(A)modes of transmission;

(B)consequences of infection, including the link between HPV and cervical cancer;

(C)the available scientific evidence on the effectiveness or lack of effectiveness of condoms in preventing infection with HPV; and

(D)the importance of regular Pap smears, and other diagnostics for early intervention and prevention of cervical cancer purposes in preventing cervical cancer.

(2)Educational material under paragraph (1), and all other relevant educational and prevention materials prepared and printed from this date forward for the public and health care providers by the Secretary (including materials prepared through the Food and Drug Administration, the Centers for Disease Control and Prevention, and the Health Resources and Services Administration), or by contractors, grantees, or subgrantees thereof, that are specifically designed to address STDs including HPV shall contain medically accurate information regarding the effectiveness or lack of effectiveness of condoms in preventing the STD the materials are designed to address. Such requirement only applies to materials mass produced for the public and health care providers, and not to routine communications.

(d)(1)(A)The Secretary shall carry out a national campaign to increase the awareness and knowledge of health care providers and women with respect to gynecologic cancers.

(B)Activities under the national campaign under subparagraph (A) shall include—

(i)maintaining a supply of written materials that provide information to the public on gynecologic cancers; and

(ii)distributing the materials to members of the public upon request.

(C)Activities under the national campaign under subparagraph (A) shall, in accordance with applicable law and regulations, include developing and placing, in telecommunications media, public service announcements intended to encourage women to discuss with their physicians their risks of gynecologic cancers. Such announcements shall inform the public on the manner in which the written materials referred to in subparagraph (B) can be obtained upon request, and shall call attention to early warning signs and risk factors based on the best available medical information.

(2)(A)Not later than 6 months after January 12, 2007, the Secretary shall submit to the Congress a report including the following:

(i)A description of the past and present activities of the Department of Health and Human Services to increase awareness and knowledge of the public with respect to different types of cancer, including gynecologic cancers.

(ii)A description of the past and present activities of the Department of Health and Human Services to increase awareness and knowledge of health care providers with respect to different types of cancer, including gynecologic cancers.

(iii)For each activity described pursuant to clause (i) or (ii), a description of the following:

(I)The funding for such activity for fiscal year 2006 and the cumulative funding for such activity for previous fiscal years.

(II)The background and history of such activity, including—

(aa)the goals of such activity;

(bb)the communications objectives of such activity;

(cc)the identity of each agency within the Department of Health and Human Services responsible for any aspect of the activity; and

(dd)how such activity is or was expected to result in change.

(III)How long the activity lasted or is expected to last.

(IV)The outcomes observed and the evaluation methods, if any, that have been, are being, or will be used with respect to such activity.

(V)For each such outcome or evaluation method, a description of the associated results, analyses, and conclusions.

(B)(i)Not later than 3 months after submitting the report required by subparagraph (A), the Secretary shall develop and submit to the Congress a strategy for improving efforts to increase awareness and knowledge of the public and health care providers with respect to different types of cancer, including gynecological cancers.

(ii)In developing the strategy under clause (i), the Secretary should consult with qualified private sector groups, including nonprofit organizations.

(3)(A)Not later than March 1, 2008, the Secretary shall ensure that all provisions of this section, including activities directed to be carried out by the Centers for Disease Control and Prevention and the Food and Drug Administration, are fully implemented and being complied with. Not later than April 30, 2008, the Secretary shall submit to Congress a report that certifies compliance with the preceding sentence and that contains a description of all activities undertaken to achieve such compliance.

(B)If the Secretary fails to submit the certification as provided for under subparagraph (A), the Secretary shall, not later than 3 months after the date on which the report is to be submitted under subparagraph (A), and every 3 months thereafter, submit to Congress an explanation as to why the Secretary has not yet complied with the first sentence of subparagraph (A), a detailed description of all actions undertaken within the month for which the report is being submitted to bring the Secretary into compliance with such sentence, and the anticipated date the Secretary expects to be in full compliance with such sentence.

(4)In carrying out the national campaign under this subsection, the Secretary shall consult with nonprofit gynecologic cancer organizations, with a mission both to conquer ovarian or other gynecologic cancer and to provide outreach to State and local governments and communities, for the purpose of determining the best practices for providing gynecologic cancer information and outreach services to varied populations.

(6)For the purpose of carrying out this subsection, there is authorized to be appropriated $16,500,000 for the period of fiscal years 2007 through 2009 and $18,000,000 for the period of fiscal years 2012 through 2014.

Notes & Related Subsidiaries

Editorial Notes

References in Text

Johanna’s Law, referred to in section catchline and subsec. (d), is Pub. L. 109–475, Jan. 12, 2007, 120 Stat. 3565, also known as the Gynecologic Cancer Education and Awareness Act of 2005, which amended this section. For complete classification of this Act to the Code, see

Short Title

of 2007 Amendment note set out under section 201 of this title and Tables. The

Effective Date

of this section, referred to in subsecs. (a)(2) and (b)(2), is the date of enactment of Pub. L. 106–554, which was approved Dec. 21, 2000.

Amendments

2010—Subsec. (d)(4). Pub. L. 111–324, § 1(b), added par. (4). Former par. (4) redesignated (6). Pub. L. 111–324, § 1(a)(1), inserted “and $18,000,000 for the period of fiscal years 2012 through 2014” after “2009”. Subsec. (d)(6). Pub. L. 111–324, § 1(a)(2), redesignated par. (4) as (6). 2007—Pub. L. 109–475, § 2(1), inserted “(Johanna’s Law)” after “papillomavirus” in section catchline. Subsec. (d). Pub. L. 109–475, § 2(2), added subsec. (d).

§247b–17 Human Papillomavirus (johanna’s Law)